Intravitreal ranibizumab as an adjunct to conventional surgery for neovascular glaucoma: a retrospective observational study of efficacy and clinical characteristics of surgical failure cases

Dan Li, Chao Li, Qing Ye · 2026

Read Intravitreal ranibizumab as an adjunct to conventional surgery for neovascular glaucoma: a retrospective observational study of efficacy and clinical characteristics of surgical failure cases by Dan Li, Chao Li, Qing Ye (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13619498.txt.

Description

Dan Li, Chao Li, and Qing Ye test whether a drug shot into the eye before surgery lifts the success of operations for a severe form of glaucoma. Their 2026 study deals with neovascular glaucoma, where poor blood flow to the retina spawns new vessels that block fluid drainage. Standard surgery often fails as fresh vessels and scars form.

The team matched 31 patients who got the drug plus surgery with 31 who had surgery alone, drawn from 62 patients treated over two years. They tracked success at twelve months, eye pressure, sight, and side effects. They also describe the traits of the cases where surgery failed, to help surgeons spot high-risk eyes early.

Catalog record

CREATORDan Li, Chao Li, Qing Ye
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13619498

Browse the full library · About the Tower of Babel